Synergy CHC Corp. SNYR
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2013-11-08
Synergy CHC Corp. statistics & valuation
Market cap$3.1M
P / S0.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Gross margin | 66.8% | 67.9% | 75.0% | 68.9% | 67.4% |
| Operating margin | -27.8% | 16.7% | 25.3% | -27.1% | -14.5% |
| Net margin | -40.6% | 6.1% | 14.8% | -31.4% | -18.2% |
| FCF margin | — | — | — | — | 3.5% |
| Return on assets | -121.4% | 13.0% | 51.8% | -177.4% | -30.8% |
| Return on equity | 53.4% | -12.8% | -23.2% | 177.0% | -155.2% |
| Debt / equity | -1.08× | -0.45× | -0.48× | — | — |
| Current ratio | 1.22 | 0.93 | 0.84 | 0.50 | 0.86 |
| Revenue growth | -12.8% | -18.6% | 45.7% | -13.2% | -5.0% |
Source: SEC EDGAR filings · CIK 0001562733 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.